Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000238269

Medchemexpress LLC (2S)-2-[[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)imidazo[4,5-b]pyridin-2-yl]methylamino]propanamide | 1233231-30-5 | 98.3% | 419.4 g/mol | C20H20F3N5O2 | 10MG
SDP

Catalog No. 5000238269
Encompass_Preferred

DSP-2230 (ANP-230) is an orally active small-molecule inhibitor of voltage-gated sodium channels, developed for research into neuropathic pain and sodium-channel pharmacology. It is used in both in vitro and in vivo studies to evaluate inhibition of Nav1.7, Nav1.8, and Nav1.9 and to probe analgesic mechanisms. The compound is supplied as a high-purity research reagent with good solubility in DMSO.

Catalog No. 50-002-38269 Supplier Medchemexpress LLC Supplier No. HY12507910MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DSP-2230 (ANP-230) is an orally active small-molecule inhibitor of voltage-gated sodium channels, developed for research into neuropathic pain and sodium-channel pharmacology. It is used in both in vitro and in vivo studies to evaluate inhibition of Nav1.7, Nav1.8, and Nav1.9 and to probe analgesic mechanisms. The compound is supplied as a high-purity research reagent with good solubility in DMSO.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.